Crispr Therapeutics Ag (CRSP)

Last Year

22-Nov-23 -- 21-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

20

0

4

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Feb-24 6:39 PM View:	27-Feb-24 Grant $75.00M	George Simeon Director		Crispr Therapeutics Ag - CRSP	100% 0 to 1.05M	0	0	--	--	Show Txns Hide Txns

15-Oct-24 6:00 PM View:	14-Oct-24 Option Sale ($50.40K)	Kasinger James R. General Counsel and Secretary		Crispr Therapeutics Ag - CRSP	13% 55.46K to 62.6K	0	0	--	--	Show Txns Hide Txns

15-Oct-24 6:00 PM View:	14-Oct-24 Option Sale ($198.68K)	Kulkarni Samarth Chief Executive Officer Director		Crispr Therapeutics Ag - CRSP	(19%) 387.38K to 312.16K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 5:45 PM View:	15-Mar-24 Option Sale ($256.16K)	Prasad Raju Chief Financial Officer		Crispr Therapeutics Ag - CRSP	100% 0 to 6.48K	0	0	--	--	Show Txns Hide Txns

24-Jun-24 5:35 PM View:	21-Jun-24 Option Sale ($188.80K)	Bruno Julianne Chief Operating Officer		Crispr Therapeutics Ag - CRSP	36% 10.2K to 13.83K	0	0	--	--	Show Txns Hide Txns